XML 38 R29.htm IDEA: XBRL DOCUMENT v3.20.4
C STOCKHOLDERS EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Dec. 07, 2020
Sep. 30, 2020
Jun. 25, 2020
Dec. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Prepaid expenses       $ 244,000   $ 395,000
Proceeds from the sale of common stock       1,000,000    
Public offering price per share       $ 14.65    
Proceeds from public offering       $ 13,600,000    
Additional shares of common stock       150,000    
Fair value of stock option       $ 28,000    
Weighted average grant date fair value       $ 5.65    
Proceeds from warrants exercised       $ 70,911 $ 297,101  
Stock options granted       7,500 1,000  
Warrants expired       55 36  
Common stock shares issued   38,730,150   39,767,058    
Common stock valued   $ 387,302   $ 397,671    
Consulting Agreements [Member]            
Total expense       $ 249,000 $ 156,000  
Series W Warrants [Member]            
Common stock price per share     $ 16.75      
Warrants expired     688,930      
Non-Qualified Stock Option Plans [Member]            
Stock options granted       10,000    
Series X [Member]            
Incremental cost       $ 85,000    
Expiration date description the expiration date of the Series X warrants was extended six months from January 13, 2021 to July 13, 2021          
Expiration date       7/13/2021    
Series Y [Member]            
Incremental cost $ 41,000          
Expiration date       8/15/2021    
Series CC [Member]            
Warrants exercised       5,000    
Warrant exercise price       $ 5.00    
Proceeds from warrants exercised       $ 25,000    
Expiration date       12/8/2021    
Series TT [Member]            
Warrants exercised       10,000    
Warrant exercise price       $ 2.24    
Proceeds from warrants exercised       $ 22,400    
Expiration date       2/5/2023    
Series UU warrants [Member]            
Incremental cost       $ 192    
Expiration date description the expiration date of Series UU warrants were extended six months from December 31, 2020 to June 30, 2021          
Series N Warrants [Member]            
Incremental cost       $ 1,000    
Expiration date description the expiration date of the Series N warrants was extended six months from February 18, 2021 to August 18, 2021          
Consultants One [Member]            
Options issued   10,000   15,000    
Ergomed [Member]            
Common stock shares held       93,521    
Common stock shares issued       9,000 98,350  
Ergomed [Member] | SPA [Member]            
Common stock valued       $ 100,000 $ 800,000  
Consultants [Member]            
Exercise price       $ 11.61    
Options issued       5,000    
Expiration date       November 17, 2022    
Consultants [Member] | Restricted Stock [Member]            
Weighted average grant date fair value       $ 12.45 $ 7.18  
Common stock issued for service, shares       15,044 15,819